Amgen, the world's largest biotechnology company, announced on Wednesday plans to build a new manufacturing plant in Singapore.
Thousand Oaks, California-based Amgen said it plans to invest around $200 million in the project, which will initially focus on the production of antibody-based drugs.
Construction, in the Tuas Biomedical Park area of Singapore, is expected to begin in the next few months.
BASF sells a majority stake in its coatings business to the investor Carlyle.
Compelling solutions through strategic partnerships
The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.
Novo Nordisk announced a global workforce reduction of approximately 9,000 positions to streamline operations and reinvest DKK 8 billion (€1 billion) in growth opportunities for diabetes and obesity treatments.
